41 results on '"Nereide Stela Santos Magalhães"'
Search Results
2. Nanoencapsulação de um peptídeo isolado de anuros: citotoxicidade in vitro em células tumorais humanas
- Author
-
José Jauro Lopes Anchiêta Júnior, Handerson Rodrigues Silva Lima, Isabella Macário Ferro Cavalcante, José Roberto de Souza de Almeida Leite, Nereide Stela Santos Magalhães, and Hercília Maria Lins Rolim
- Subjects
Antineoplásicos ,Citotoxicidade in vitro ,Dermaseptina 01 ,Lipossomas ,Peptídeos catiônicos ,Tetrazólio ,Pharmaceutical industry ,HD9665-9675 ,Pharmacy and materia medica ,RS1-441 - Abstract
A terapia antineoplásica tradicional apresenta algumas limitações que podem ser superadas através da utilização dos lipossomas. Estes nanossistemas de carreamento possibilitam o direcionamento de fármacos e reduzem efeitos secundários. Alguns peptídeos catiônicos sintetizados na pele de anuros apresentam atividade citotóxica seletiva (microorganismos e/ ou tumores). Neste sentido, espécies do gênero Phyllomedusa secretam as dermaseptinas. Objetivouse neste estudo, avaliar a citotoxicidade in vitro da dermaseptina 01 (DS 01) livre e encapsulada em lipossomas unilamelares pequenos (SUVs) em células tumorais humanas. Os lipossomas foram preparados pelo método de hidratação do filme lipídico seguido de sonicação. Foram produzidas formulações neutras e catiônicas, convencionais e furtivas. A citotoxicidade foi analisada em células tumorais de pulmão (NCI-H292), cólon (HT-29) e laringe (HEp-2), pelo ensaio de redução do sal tetrazólio (MTT) em placas de 96 poços. Os lipossomas foram submetidos a testes de estabilidade acelerada e em longo prazo. Em NCI-H292, a DS 01 livre apresentou efeito citostático médio de 35,6%. A encapsulação do peptídeo em lipossomas convencionais neutros aumentou o efeito, ao contrário dos furtivos. Para HT-29 e HEp-2, a DS 01 livre inibiu o crescimento celular em aproximadamente 50%, em média. A encapsulação em lipossomas catiônicos potencializou o efeito; os lipossomas convencionais inibiram na faixa de 80% e os furtivos, mais que 95% para as duas linhagens celulares. A DS 01, um peptídeo catiônico antimicrobiano, apresentou efeito citotóxico in vitro para células tumorais humanas que foi potencializado com a nanoencapsulação.
- Published
- 2014
3. Tissue response and retention of micro- and nanosized liposomes in infarcted mice myocardium after ultrasound-guided transthoracic injection
- Author
-
Laís de Macêdo Ferreira Santos, Breno Cardim Barreto, Helenita Costa Quadros, Cássio Santana Meira, Rafaela de Siqueira Ferraz-Carvalho, Juliana de Souza Rebouças, Simone Garcia Macambira, Juliana Fraga Vasconcelos, Bruno Solano de Freitas Souza, Milena Botelho Pereira Soares, Nereide Stela Santos-Magalhães, and Fabio Rocha Formiga
- Subjects
Mice ,Myocardium ,Liposomes ,Myocardial Infarction ,Animals ,Pharmaceutical Science ,General Medicine ,Ultrasonography, Interventional ,Ultrasonography ,Biotechnology - Abstract
Different carrier systems have been investigated for myocardial delivery of biopharmaceuticals for heart disease. Here, we aimed to evaluate the heart retention and tissue response of liposomes intended for cardiac drug delivery. Liposomes were produced by the lipid thin film hydration method followed by sonication. Cytocompatibility tests were performed in murine L929 fibroblasts and H2c9 cardiomyocytes using the Alamar Blue assay. In vivo experiments were assessed in a model of myocardial infarction induced by isoproterenol in mice. Cardiac delivery of fluorescent liposomes (rhodamine B-labeled) with different mean sizes (165 nm, 468 nm, 1551 nm and 1954 nm) was performed by ultrasound-guided transthoracic injection. After three days, mice were euthanized for histological evaluation using optical and fluorescence microscopy. No cytotoxic lipid concentrations were determined in the range 9.3 - 120 µM for fibroblasts and cardiomyocytes exposed to liposomes. In vivo, large liposomes induced significant inflammation in myocardium compared with the control group (p 0.0001). In contrast, heart mice injected with 468 nm-sized liposomes exhibited a lower number of inflammatory cells. Still, a greater tissue retention 72 h post-injection was found. Therefore, this study demonstrated the feasibility of the echocardiography-guided percutaneous injection to deliver liposomes successfully into the myocardium in a minimally invasive manner. In addition, these findings indicate the potential of liposomes as carriers of biopharmaceuticals for myocardial delivery, supporting the development of further research on these delivery systems for heart disease.
- Published
- 2022
4. Development of levan-coated PIBCA nanoparticles and their antiproliferative activity against MDA-MB-231 and B16F10 cells
- Author
-
Andreza Tallyne de Aguiar Silva, Iago Dillion Lima Cavalcanti, Marcela de Araújo Sobral, Gláucia Manoella de Souza Lima, Otília Deusdênia Loiola Pessoa, Nereide Stela Santos Magalhães, Cynthia Gisele Oliveira Coimbra, and Mariane Cajubá de Britto Lira Nogueira
- Subjects
Colloid and Surface Chemistry - Published
- 2023
5. FORMULATION OF LIPOSOMES FROM LEVANA
- Author
-
Agenor Tavares Jácome-Junior, Irapuan Oliveira Pinheiro, Amanda Mota Vieira, Catarina Paula da Silva Ramos, Glícia Maria Torres Calazans, and Nereide Stela Santos-Magalhães
- Published
- 2022
6. Natural products and combination therapy as strategies against bacterial biofilm
- Author
-
Luís André de Almeida Campos, João Victor de Oliveira Santos, Iago Dillion Lima Cavalcanti, Azael Francisco Silva Neto, Mariane Cajubá de Britto Lira Nogueira, Nereide Stela Santos-Magalhães, and Isabella Macário Ferro Cavalcanti
- Published
- 2023
7. Interaction study between vancomycin and liposomes containing natural compounds against methicillin-resistant Staphylococcus aureus clinical isolates
- Author
-
Isabella Macário Ferro Cavalcanti, Talita Gomes Calaça Menezes, Luís André de Almeida Campos, Milena Sales Ferraz, Maria Amélia Vieira Maciel, Maria Nelly Psiotano Caetano, and Nereide Stela Santos-Magalhães
- Subjects
β-lapachone ,Usnic acid ,Liposomes ,Methicillin-resistant Staphylococcus aureus (MRSA) ,Synergism. ,Pharmacy and materia medica ,RS1-441 - Abstract
ABSTRACT The treatment of infections caused by resistant microorganisms is limited, and vancomycin (VAN) treatment failures for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia are not uncommon, even when MRSA clinical isolates are susceptible to VAN. Thus, this study proposed the association of VAN with usnic acid and β-lapachone encapsulated into liposomes as a novel therapeutic option for infections caused by MRSA. Liposomes containing β-lap (β-lap-lipo) or usnic acid (UA-lipo) were prepared by the thin lipid film hydration method followed by sonication. Antimicrobial activity against MRSA clinical isolates was investigated by the microdilution method according to the Clinical and Laboratory Standards Institute (CLSI). The interaction studies were carried out using the checkerboard method and epsilometer test (Etest). The interaction between VAN and β-lap or β-lap-lipo was synergistic (FICI = 0.453 and FICI = 0.358, respectively). An additive interaction between VAN and UA (FICI = 0.515) was found. UA-lipo resulted in synergism with VAN (FICI = 0.276). The Etest reproduced the results obtained by the checkerboard method for approximately 82% of the analysis. Thus, the present study demonstrated that VAN in combination with UA-lipo, β-lap or β-lap-lipo synergistically enhanced antibacterial activity against MRSA.
- Published
- 2018
- Full Text
- View/download PDF
8. Fucoidan-Coated Liposomes: A Target System to Deliver the Antimicrobial Drug Usnic Acid to Macrophages Infected with Mycobacterium tuberculosis
- Author
-
Taciana Lima Salviano, Daniel Charles dos Santos Macêdo, Bezerra Sidicleia Costa Silva, Fabrício Oliveira Souto, Maria da Paz Carvalho da Silva, Jaciana S. Aguiar, Lílian Maria Lapa Montenegro Pimentel, Nereide Stela Santos Magalhães, Luanna de Ângelis Correia de Sousa, Mariane Cajubá de Britto Lira Nogueira, Rafaela de Siqueira Ferraz Carvalho, Vanessa Santos de Arruda Barbosa, Alexandre José da Silva Góes, Teresinha Gonçalves da Silva, and Marcela Araújo Pereira
- Subjects
chemistry.chemical_classification ,Liposome ,biology ,Chemistry ,Fucoidan ,Vesicle ,Biomedical Engineering ,Usnic acid ,Pharmaceutical Science ,Medicine (miscellaneous) ,Bioengineering ,biology.organism_classification ,Antimicrobial ,Polysaccharide ,Molecular biology ,Mycobacterium tuberculosis ,chemistry.chemical_compound ,General Materials Science ,Cytotoxicity - Abstract
The present study describes the use of fucoidan, a negative sulfated polysaccharide, as a coating material for the development of liposomes targeted to macrophages infected with Mycobacterium tuberculosis. First, fucoidan was chemically modified to obtain a hydrophobized-fucoidan derivative (cholesteryl-fucoidan) using a two-step microwave-assisted (μW) method. The total reaction time was decreased from 14 hours to 1 hour while maintaining the overall yield. Cholesterylfucoidan was then used to prepare surface-modified liposomes containing usnic acid (UA-LipoFuc), an antimicrobial lichen derivative. UA-LipoFuc was evaluated for mean particle size, polydispersity index (PDI), surface charge (ζ), and UA encapsulation efficiency. In addition, a cytotoxicity study, competition assay and an evaluation of antimycobacterial activity against macrophages infected with M. tuberculosis (H37Ra) were performed. When the amount of fucoidan was increased (from 5 to 20 mg), vesicle size increased (from 168 ± 2.82 nm to 1.18 ± 0.01 μm). Changes in from +20 ± 0.41 mV for uncoated liposomes to −5.41 ± 0.23 mV for UA-LipoFuc suggested that the fucoidan was placed on the surface of the liposomes. UA-LipoFuc exhibited a lower IC50 (8.26 ± 1.11 μM) than uncoated liposomes (18.37 ± 3.34 μM), probably due to its higher uptake. UA-LipoFuc5 was internalized through the C-type carbohydrate recognition domain of the cell membrane. Finally, usnic acid, both in its free form and encapsulated in fucoidan-coated liposomes (UA-LipoFuc5), was effective against infected macrophages. Hence, this preliminary investigation suggests that encapsulated usnic acid will aid in further studies related to infected macrophages and may be a potential option for tuberculosis treatment.
- Published
- 2021
9. Validation of a UV-spectrophotometric analytical method for determination of LPSF/AC04 from inclusion complex and liposomes
- Author
-
Rafaela Siqueira Ferraz, Elisângela Afonso Moura Mendonça, Jéssica Priscila Avelino Silva, Isabella Macário Ferro Cavalcanti, Mariane Cajubá Britto Lira-Nogueira, Suely Lins Galdino, Ivan Rocha Pitta, Maria do Carmo Alves Lima, and Nereide Stela Santos-Magalhães
- Subjects
Espectrofotometria UV/análise quantitativa/validação de método ,Derivados acridínicos/determinação ,Complexos de inclusão ,Lipossomas ,Pharmacy and materia medica ,RS1-441 - Abstract
The aim of this study was to develop and validate a UV spectrophotometric method for determination of LPSF/AC04 from inclusion complex and encapsulated into liposomes. The validation parameters were determined according to the International Conference on Harmonisation (ICH) and National Health Surveillance Agency (ANVISA) guidelines. LPSF/AC04 was determined at 250 nm in methanol by a UV spectrophotometric method, exhibiting linearity in the range from 0.3 to 2 µg.mL−1 (Absorbance=0.18068 x [LPSF/AC04 µg.mL-1] + 0.00348), (r2=0.9995). The limits of detection and quantification were 0.047µg.mL−1 and 0.143µg.mL−1, respectively. The method was accurate, precise, reproducible and robust since all the samples analyzed had coefficient of variation of less than 5% and no statistically significant difference between theoretical and practical concentrations was detected. Thus, a rapid, simple, low cost and sensitive spectrophotometric method was developed and validated for determining the content of inclusion complex and liposomes containing LPSF/AC04.
- Published
- 2015
- Full Text
- View/download PDF
10. Isothermal titration calorimetry (ITC) as a promising tool in pharmaceutical nanotechnology
- Author
-
Iago Dillion Lima Cavalcanti, Francisco Humberto Xavier Junior, Nereide Stela Santos Magalhães, and Mariane Cajubá de Britto Lira Nogueira
- Subjects
Pharmaceutical Science - Published
- 2023
11. Desafios da técnica de obtenção de microesferas de Bacillus thuringiensis israelensis associado a óleo essencial de Croton rhamnifolioides/ Challenges of Bacillus thuringiensis israelensis Microsphere techniques associated with Croton rhamnifolioides essential oil
- Author
-
Silvana Souza da Cunha Cavalcante, Ronaldo Faustino Da Silva, Sofia Suely Ferreira Brandão Rodrigues, Nereide Stela Santos -Magalhães, Maria Alice Varjal de Melo Santos, Milena Sales Ferraz, Laura da Silva Moura, and Eduardo José Alécio De Oliveira
- Subjects
Marketing ,Pharmacology ,Organizational Behavior and Human Resource Management ,Strategy and Management ,Drug Discovery ,Pharmaceutical Science - Published
- 2021
12. Zein nanoparticles for drug delivery: Preparation methods and biological applications
- Author
-
Luís André de Almeida Campos, Azael Francisco Silva Neto, Maria Cecília Souza Noronha, Milena Ferreira de Lima, Isabella Macário Ferro Cavalcanti, and Nereide Stela Santos-Magalhães
- Subjects
Pharmaceutical Science - Published
- 2023
13. Nanotechnology and COVID-19: quo vadis?
- Author
-
João Lima Tavares, Iago Dillion Lima Cavalcanti, Nereide Stela Santos Magalhães, and Mariane Cajubá de Britto Lira Nogueira
- Subjects
Modeling and Simulation ,General Materials Science ,Bioengineering ,General Chemistry ,Condensed Matter Physics ,Atomic and Molecular Physics, and Optics - Published
- 2022
14. ENCAPSULATION INTO STEALTH LIPOSOMES ENHANCED THE ANTITUMOR ACTION OF RECOMBINANT Cratylia mollis LECTIN EXPRESSED IN Escherichia coli
- Author
-
Cássia Regina Albuquerque da Cunha, Luis Cláudio Nascimento Da Silva, Fábio José Fidélis Almeida, Milena Sales Ferraz, Nathalia Varejão, Marina Falcão de Souza Cartaxo, Rita De Cássia Mendonça De Miranda, Francisco Carlos Amanajás de Aguiar Júnior, Noemia Pereira da Silva Santos, Luana Cassandra Breitenbach Barroso Coelho, Nereide Stela Santos-Magalhães, and Maria Tereza dos Santos Correia
- Subjects
Immunomodulation ,Lectins ,Pharmaceutical Preparations ,Cancer ,heterologous expression ,Microbiology ,QR1-502 - Abstract
This study evaluated the in vivo antitumor potential of new recombinant lectin from seeds of Cratylia mollis (rCramoll) expressed in Escherichia coli, free or encapsulated in stealth liposomes, using mice transplanted with sarcoma 180. rCramoll-loaded stealth liposomes (rCramoll-lipo) were formulated by hydration of the lipid film followed by cycles of freezing and thawing, and about 60% of rCramoll was encapsulated. This novel preparation showed particle size, polydispersity index, and pH suitable for the evaluation of antitumor activity in vivo. Tumor growth inhibition rates were 68% for rCramoll and 80% for rCramoll-lipo. Histopathological analysis of the experimental groups showed that both free and encapsulated lectin caused no changes in the kidneys of animals. Hematological analysis revealed that treatment with rCramoll-lipo significantly increased leukocyte concentration when compared with the untreated and pCramoll group. In conclusion, the encapsulation of rCramoll in stealth liposomes improves its antitumor activity without substantial toxicity; this approach was more successful than the previous results reported for pCramoll loaded into conventional liposomes. At this point, a crucial difference between the antitumor action of free and encapsulated rCramoll was found along with their effects on immune cells. Further investigations are required to elucidate the mechanism(s) of the antitumor effect induced by rCramoll.
- Published
- 2016
- Full Text
- View/download PDF
15. Cardiac Regeneration using Growth Factors: Advances and Challenges
- Author
-
Juliana de Souza Rebouças, Nereide Stela Santos-Magalhães, and Fabio Rocha Formiga
- Subjects
Infarto do Miocárdio ,Isquemia Miocárdica ,Remodelação Vascular ,Peptídeos e Proteínas de Sinalização Intercelular ,Terapia Baseada em Transplante de Células e Tecidos ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Abstract Myocardial infarction is the most significant manifestation of ischemic heart disease and is associated with high morbidity and mortality. Novel strategies targeting at regenerating the injured myocardium have been investigated, including gene therapy, cell therapy, and the use of growth factors. Growth factor therapy has aroused interest in cardiovascular medicine because of the regeneration mechanisms induced by these biomolecules, including angiogenesis, extracellular matrix remodeling, cardiomyocyte proliferation, stem-cell recruitment, and others. Together, these mechanisms promote myocardial repair and improvement of the cardiac function. This review aims to address the strategic role of growth factor therapy in cardiac regeneration, considering its innovative and multifactorial character in myocardial repair after ischemic injury. Different issues will be discussed, with emphasis on the regeneration mechanisms as a potential therapeutic resource mediated by growth factors, and the challenges to make these proteins therapeutically viable in the field of cardiology and regenerative medicine.
- Published
- 2016
- Full Text
- View/download PDF
16. LARVICIDAL ACTIVITY OF CROTON RHAMNIFOLIOIDES(PAX HOFFM) ESSENTIAL OIL ENCAPSULATED IN A POLYMERIC NANOSYSTEM AGAINST THE MOSQUITO AEDES AEGYPTI
- Author
-
Sofia Suely Ferreira Brandão, Nereide Stela Santos Magalhães, Maria Alice Varjal de Melo-Santos, Daniela do Amaral Ferraz Navarro, and Andreia Gregório Da Silva Santos
- Subjects
Multidisciplinary ,biology ,Traditional medicine ,law ,General Chemistry ,Pharmacy ,Aedes aegypti ,biology.organism_classification ,Croton ,Essential oil ,Education ,law.invention - Abstract
Aedes aegypti is a species of mosquito with wide distribution worldwide, involved in the cycles of transmission of dengue, Zika and chikungunya. The lack of vaccines for most of these arboviruses highlights the importance of vector control as a measure to reduce the incidence of these diseases. Several researches have been carried out in order to find substances of plant origin that are candidates for the control of A. aegypti. In this sense, medicinal plants that also have an insecticidal action have shown promise for the development of new products, environmentally safer than traditional chemical insecticides. The objective of this work was to evaluate the larvicidal activity of the essential oil of the leaves of Croton rhamnifolioides and its formulation in nanocapsules for A. aegypti. The essential oil was extracted by hydrodistillation and analyzed by gas chromatography coupled to a mass spectrometer (CG/MS). Formulations were produced containing concentrations of pure oil, which ranged from 40 to 80 μg/mL and polycaprolactone nanocapsules with concentrations from 30 to 120 μg/mL. Larvicide tests were performed using varying concentrations of an aqueous suspension, in triplicates, containing 20 larvae / concentration, in addition to an untreated control. As a result, the essential oil had an average content that varied between 1.4% and 0.58%, depending on the time of collection and, as main constituents, eucalyptol (16.57%) and (E) -cariophylene (11, 32%). LC50 values ranged from 26.3 μg/mL to 52.2 μg/mL and CL90 from 37.8 μg/mL to 68.7 μg/mL for pure oil. In encapsulated oil, the LC50 = 63.4 μg/mL and the LC90 = 104.8 μg/mL. The pure oil of Croton rhamnifolioides was considered more active against the larvae of A. aegypti than the encapsulated one, although both have great potential for application as a larvicide.
- Published
- 2020
17. Nanotechnological Therapeutic Strategies to Treat of Biofilm-Producing Gram-Positive and Gram-Negative Pathogenic Bacteria
- Author
-
Nereide Stela Santos-Magalhães, Isabella Macário Ferro Cavalcanti, Azael Franscisco Silva Neto, de João Victor de Oliveira Santos, Iago Dillion Lima Cavalcanti, Mariane Cajubá de Britto Lira-Nogueira, and Luís André de Almeida Campos
- Subjects
Biofilm ,medicine ,Pathogenic bacteria ,Biology ,medicine.disease_cause ,Gram ,Microbiology - Published
- 2022
18. Desenvolvimento e validação de método analítico em CLAE-UV para a quantificação de ácido retinóico em microcápsulas de alginato e quitosana
- Author
-
Fabiana Toledo Velloso, Rafaela Siqueira Ferraz, Ana Amélia Moreira Lira, Davi Pereira de Santana, and Nereide Stela Santos-Magalhães
- Subjects
Cromatografia líquida de alta eficiência ,Espectroscopia ,Ácido retinóico ,Microcápsulas ,Formulações farmacêuticas ,High performance liquid chromatography ,Spectroscopy ,Retinoic acid ,Microcapsules ,Pharmaceutical formulations ,Pharmacy and materia medica ,RS1-441 - Abstract
O ácido retinóico (AR) tem sido utilizado para o tratamento de acne severa, rugas, estrias e celulite, no entanto, provoca irritação na pele e sofre rápida degradação quando exposto à luz e ao calor. Métodos analíticos rápidos para quantificação do AR são, portanto, necessários para ensaios de cinética de liberação in vitro. Nesse contexto, o objetivo deste trabalho foi desenvolver e validar um método rápido e sensível para o doseamento do AR em microcápsulas de alginato/quitosana contendo óleo de babaçu dispersas em gel natrosol® por cromatografia líquida de alta eficiência associada à espectroscopia UV e aplicá-lo na avaliação do perfil de liberação in vitro dessas formulações. As análises foram realizadas em modo isocrático utilizando coluna C18 de fase reversa 150 x 4,6 mm (5 μm) com detecção a 350 nm. A fase móvel foi constituída de metanol e ácido acético 1% (85:15 v/v) com vazão de 1,8 mL/minuto. A faixa de linearidade do método foi de 0,5 a 60 μg/mL (r² = 0,999). O método validado mostrou-se sensível, específico, exato, preciso, de baixo custo e o tempo de retenção do AR foi de 5,8 ± 0,4 minutos sendo, desta forma, mais rápido do que os relatados na literatura.Retinoic acid (RA) has been used in the treatment of severe acne, wrinkles and cellulite. However, it induces skin irritation and rapidly suffers degradation under light and high temperate exposure. Rapid analytical methods to quantify retinoic acid are therefore mandatory for in vitro drug release studies. In this framework, the aim of this study was to develop and validate a rapid and responsive method to quantify the RA in microcapsules of chitosan and alginate containing babassu oil dispersed in natrosol® hydrogel using high performance liquid chromatography (HPLC). Furthermore this method was used to quantify in vitro release kinetics of RA from microcapsules. The analyses have been carried through an isocratic HPLC-UV method using a reversed phase 150 x 4.6 mm C18 (5μm) column, a mobile phase constituted of methanol and 1% acetic acid (85:15) at a flow rate of 1.8 mL/min and detection at 350 nm. The linearity range was 0.5-60 μg/mL (r² = 0.999). The validated HPLC-UV method was responsive, specific, accurate, precise, and economic and the RA retention time was 5.8 ± 0.4 minutes, being therefore, faster than that previously reported.
- Published
- 2009
- Full Text
- View/download PDF
19. Nanotechnology and COVID-19
- Author
-
João Lima, Tavares, Iago Dillion Lima, Cavalcanti, Nereide Stela, Santos Magalhães, and Mariane Cajubá de Britto, Lira Nogueira
- Abstract
The pandemic COVID-19 has worried everyone due to the high mortality rate and the high number of people hospitalized with severe acute respiratory syndrome caused by SARS-CoV-2. Given the seriousness of this disease, several companies and research institutions have sought alternative treatment and/or prevention methods for COVID-19. Due to its versatility, nanotechnology has allowed the development of protective equipment and vaccines to prevent the disease and reduce the number of severe COVID-19 cases. Thus, this article combined the main works and products developed in a nanotechnological field for COVID-19. We performed a literature search using the keywords "COVID-19," "SARS-CoV-2," "nanoparticles," "nanotechnology," and "liposomes" in the SciELO, Scifinder, PubMed, Sciencedirect, ClinicalTrials, and Nanotechnology Products databases Database. The data survey indicated 48 articles, 62 products, and 32 patents. The use of nanotechnology against COVID-19 has brought benefits in several parameters of this disease, helping develop rapid diagnostic tests that release the result in 10 min, as well as developing vaccines containing genetic material from SARS-CoV-2 (DNA, mRNA, and protein subunits). Nanotechnology is an exceptional ally against COVID-19, contributing to the most diverse areas, helping both prevent, diagnose, and treat COVID-19.
- Published
- 2021
20. Does Oncocalyxone A (oncoA) have intrinsic fluorescence?
- Author
-
Iago Dillion Lima Cavalcanti, Paulo Euzébio Cabral Filho, Adriana Fontes, Rafael Matos Ximenes, Fabrício Oliveira Souto, Otília Deusdênia Loiola Pessoa, Mariane Cajubá de Britto Lira Nogueira, and Nereide Stela Santos Magalhães
- Subjects
Photochemotherapy ,Oncology ,Doxorubicin ,Cell Line, Tumor ,Biophysics ,Humans ,Nanoparticles ,Anthraquinones ,Pharmacology (medical) ,Dermatology ,Fluorescence ,Fluorescent Dyes - Abstract
Oncocalyxone A (oncoA) is a quinone extracted from the Cordia oncocalyx plant. This compound has pharmacological properties, such as anti-inflammatory, analgesic, and cytotoxic activities, among others. OncoA presents a similar chemical structure to doxorubicin, a drug used in cancer treatment, which possesses an intrinsic fluorescence explored in various studies, including those using doxorubicin-loaded nanoparticles. Thus, due to the chemical structural similarity, the question arose whether oncoA could also show autofluorescence. Therefore, this study proposed to characterize the absorption and emission spectral profiles of oncoA and analyze if this compound could be used as a fluorescent probe.For this, fucoidan-coated polyisobutylcyanoacrylate (PIBCA) nanoparticles containing oncoA were prepared, and an uptake study was performed using a human metastatic breast cancer cell line (MDA-MB-231 cells).OncoA presented a maximum emission wavelength in the blue region, near 430 nm, at 350 nm excitation, compatible with standard microscope optics. Fluorescence microscopy analyses showed that oncoA-loaded PIBCA nanoparticles were internalized by MDA-MB-231 cells under incubation times as shorter as 15 min.According to these findings, oncoA-encapsulated nanoparticles are promising fluorescent probes and could be useful for cellular uptake studies.
- Published
- 2022
21. Validation of an HPLC–UV Method for Quantifying Oncocalyxone A in Different Media and Nanocapsules
- Author
-
Rafael Matos Ximenes, Nereide Stela Santos-Magalhães, Francisco Humberto Xavier-Júnior, Otília Deusdênia L. Pessoa, and Cybelle Alves Tavares
- Subjects
Chromatography ,010405 organic chemistry ,Chemistry ,010401 analytical chemistry ,Organic Chemistry ,Clinical Biochemistry ,Aqueous two-phase system ,01 natural sciences ,Biochemistry ,Nanocapsules ,0104 chemical sciences ,Analytical Chemistry ,Partition coefficient ,Drug delivery ,Copaiba ,Cordia oncocalyx ,Solubility ,Auxemma oncocalyx - Abstract
Oncocalyxone A (onco A) isolated from heartwood of Cordia oncocalyx (Auxemma oncocalyx), exhibits antitumor, analgesic and anti-inflammatory activities. In order to produce drug delivery systems containing onco A, the objective of this study was to develop and validate an HPLC method for quantifying onco A in different media and nanocapsules. The validation method was performed according to ICH guidelines for pharmaceutical products. The solubility of onco A was determined in deionized water, simulated gastric and intestinal fluids, buffer solutions at pH 5.5, 7.0, 9.0 and oils: copaiba, soybean and medium-chain triglycerides. The partition coefficients of onco A between n-octanol, oils and aqueous phase were determined at 25 °C. Accuracy, intra- and inter-day precision values presented low random errors (less than or equal to 2.53, 2.21 and 3.12%, respectively). Onco A solubility was greater in water, buffer solutions, and simulated gastric and intestinal fluids (817 ± 54 μg mL−1) than in oils (434 ± 25 μg mL−1). Onco A showed hydrophilic characteristics (log P
- Published
- 2019
22. ConA-Coated Liposomes as a System to Delivery β-Lapachone to Breast Cancer Cells
- Author
-
Milena Sales Ferraz, Victor Passos Gibson, Maria Clara Barros, Nereide Stela Santos Magalhães, Larissa Constantino França, Mariane Cajubá de Britto Lira-Nogueira, and Francisco Humberto Xavier-Júnior
- Subjects
Pharmacology ,Cancer Research ,Liposome ,biology ,Chemistry ,chemical and pharmacologic phenomena ,Isothermal titration calorimetry ,Breast Neoplasms ,Concanavalin A ,Cancer cell ,Liposomes ,Fluorescence microscope ,biology.protein ,Zeta potential ,Biophysics ,Molecular Medicine ,Humans ,Avidity ,Female ,Cytotoxicity ,Naphthoquinones - Abstract
Background: Target treatment using site-specific nanosystems is a hot topic for treating several diseases, especially cancer. Objective: The study was set out to develop site-specific liposomes using ConcanavalinA (ConA) to target β- lapachone(β-lap) to human breast cancer cells. Methods: Liposomes were prepared and characterized according to diameter size, zeta potential, ConA conjugation(%) and β-lap encapsulation efficiency (%). Isothermal Titration Calorimetry evaluated the binding energy between the biomolecules, which compose of the liposomes. ConA avidity was assessed before and after conjugation. Cytotoxicity was evaluated, and fluorescence microscopy was performed to investigate the influence of ConA influenced on MCF-7 uptake. Results: Uncoated and ConA-coated liposomes presented size, and zeta potential values from 97.46 ± 2.01 to 152.23 ± 2.73 nm, and -6.83 ± 0.28 to -17.23 ±0.64 mV, respectively. Both ConA conjugation and β-lap encapsulation efficiency were approximately 100%. The favorable and spontaneous process confirmed the binding between ConA and the lipid. Hemagglutination assay confirmed ConA avidity once Lipo-ConA and Lipo-PEG-ConA were able to hemagglutinate the red blood cells at 128-1 and 256-1, respectively. Lipo-ConA was not cytotoxic, and the site-specific liposomes presented the highest toxicity. ConA-coated liposomes were more internalized by MCF7 than uncoated-liposomes. Conclusion: Therefore, the presence of ConA on the surface of liposomes influenced MCF7 uptake, in that way could be used as a promising site-specific system to target β-lap to cancer cells.
- Published
- 2021
23. Microencapsulation of Lactobacillus acidophilus La-05 and incorporation in vegan milks: Physicochemical characteristics and survival during storage, exposure to stress conditions, and simulated gastrointestinal digestion
- Author
-
Marciane Magnani, Ana Julia Alves Aguiar Athayde, Laênia Angélica Andrade Lopes, Isabella Araújo Portela, Thayza Christina Montenegro Stamford, Rafaela de Siqueira Ferraz Carvalho, Marta Suely Madruga, Nereide Stela Santos Magalhães, Carlos Eduardo Barão, and Tatiana Colombo Pimentel
- Subjects
030309 nutrition & dietetics ,Gastrointestinal digestion ,law.invention ,Chitosan ,03 medical and health sciences ,chemistry.chemical_compound ,Freeze-drying ,Probiotic ,0404 agricultural biotechnology ,Lactobacillus acidophilus ,law ,Animals ,Humans ,Food science ,Microparticle ,Vegans ,0303 health sciences ,Probiotics ,04 agricultural and veterinary sciences ,040401 food science ,Rice milk ,Milk ,chemistry ,Digestion ,Stress conditions ,Food Science - Abstract
The effect of microencapsulation of L. acidophilus La-05 (8 log CFU/mL) by external ionic gelation technique in alginate (30 g/L; AM) and alginate coated with a low molecular weight chitosan solution (5 g/L; AC5M) on the survival of the freeze-dried probiotic culture during storage (7 °C; 0, 7, 15, 30, 60, 90 and 120 days), and exposure to temperature (72, 85 and 90 °C), pH (2, 4, and 6), and NaCl (10, 15 and 20 g/L) were studied. Furthermore, vegan milks (soybean and rice milks) added with microencapsulated probiotic cultures were evaluated for the physicochemical characteristics and survival of the probiotic culture during refrigerated storage (7 °C; 7 days) and in vitro digestion. Free cells were used as control. AM and AC5M showed similar microencapsulation yield (>90%) with uniform and spherical microparticles dispersed without agglomeration. Scanning electron microscopy showed that chitosan was able to cover the porous structure of the alginate particles, resulting in a more stabilized microparticle. The microencapsulation provided higher probiotic protection to storage, thermal treatment, NaCl and pH (decreases of ~1 log CFU/mL) compared to the free cells (decreases of ~3, 4, 2 and 3 log CFU/mL, respectively), and increased probiotic survival during refrigerated storage and in vitro digestion of vegan milks compared to free cells (decreases of ~1 and 4 log CFU/mL, respectively). Only microencapsulated probiotic cultures (AM and AC5M) maintained suitable probiotic counts (>6 log CFU/mL) during storage, exposure to stress conditions and simulated gastrointestinal digestion. Chitosan coating increased the probiotic survival in the vegan milks during refrigerated storage. Microencapsulation by external ionic gelation in alginate proved to be a suitable microencapsulation technique to improve the probiotic survival to storage, stress conditions (temperature, pH and NaCl) and simulated gastrointestinal conditions. This was the first study that evaluated the addition of probiotic cultures to rice and soybean milks, proving that the vegan milks could be considered suitable carriers for microencapsulated probiotic cultures.
- Published
- 2020
24. Fucoidan-coated PIBCA nanoparticles containing oncocalyxone A: Activity against metastatic breast cancer cells
- Author
-
Otília Deusdênia L. Pessoa, Nereide Stela Santos Magalhães, Iago Dillion Lima Cavalcanti, Mariane Cajubá de Britto Lira-Nogueira, and Rafael Matos Ximenes
- Subjects
Chemistry ,Fucoidan ,Pharmaceutical Science ,Nanoparticle ,Emulsion polymerization ,medicine.disease ,Hemolysis ,chemistry.chemical_compound ,Differential scanning calorimetry ,In vivo ,Toxicity ,medicine ,Cytotoxicity ,Nuclear chemistry - Abstract
Background Oncocalyxone A (oncoA) is a natural benzoquinone isolated from Cordia oncocalyx, which exhibits many biological activities such as anti-tumor, anti-inflammatory, antioxidant, and hypoglycemic. However, it presents renal, cardiac, and pulmonary toxicity, which can be a limiting factor. The encapsulation of oncoA in polymeric nanoparticles can enhance its therapeutic effect, while reducing its toxicity. Objective Thus, this study aimed to develop nanoparticles of poly (isobutyl cyanoacrylate) containing oncoA, and to evaluate its activity against metastatic breast cancer cells. Methods The nanoparticles were obtained using the anionic emulsion polymerization technique and characterized by Fourier-transform Infrared spectroscopy (FT-IR), Scanning Electron Microscopy (SEM), Energy Dispersive X-Ray Analysis (EDX), Differential Scanning Calorimetry (DSC), and Thermogravimetry (TG), in addition to studies of long-term stability, including different pH, and blood compatibility. Antiproliferative activity was assessed by MTT and cell migration assays. Results The nanoparticles were obtained with a particle size of 305 ± 6.49 nm and encapsulation rate of 101.5 ± 1.4%, and were stable at different pH over 7 months. The nanoparticles did not induce hemolysis. The encapsulation of oncoA in fucoidan-coated PIBCA nanoparticles increased its cytotoxicity on MDA-MB-231 cells, and inhibited cell migration. Conclusion In conclusion, fucoidan-coated PIBCA nanoparticles containing oncoA may be a promising alternative for further anticancer in vivo studies.
- Published
- 2021
25. Ocular delivery of moxifloxacin-loaded liposomes
- Author
-
Nelise de Paiva Lucena, Nereide Stela Santos Magalhães, Rafaela de Siqueira Ferraz Carvalho, Milena Sales Ferraz, Anivaldo Pereira Duarte Júnior, Rodrigo Pessoa Cavalcanti Lira, Bruna Marília Alves dos Santos, and kaline sandrelli amorim ferreira
- Subjects
0206 medical engineering ,Drug delivery system ,Moxifloxacin ,Biological Availability ,Aqueous humor ,02 engineering and technology ,Aqueous Humor ,Drug Delivery Systems ,lcsh:Ophthalmology ,Lipid film ,In vivo ,medicine ,Drug encapsulation ,Nanotechnology ,Animals ,Chromatography, High Pressure Liquid ,Liposome ,Endophthalmitis ,Sistemas de liberação de medicamentos ,Chromatography ,Nanotecnologia ,Chemistry ,Animais ,Endoftalmite ,General Medicine ,021001 nanoscience & nanotechnology ,bacterial infections and mycoses ,020601 biomedical engineering ,Controlled release ,Naniopartículas ,Coelhos ,Anti-Bacterial Agents ,Lipossomos ,Ophthalmology ,lcsh:RE1-994 ,Liposomes ,Models, Animal ,Nanoparticles ,Female ,Particle size ,Rabbits ,Fluoroquinolonas ,Injections, Intraocular ,0210 nano-technology ,medicine.drug ,Fluoroquinolones - Abstract
Purpose: To determine the release profile of moxifloxacin encapsulated in liposomes in the aqueous humor as a controlled release system for intracameral application. Methods: Liposomes containing moxifloxacin were obtained using the lipid film hydration method and were characterized by particle size and encapsulation efficiency. Female rabbits were used for the in vivo profile release study. Liposomes containing moxifloxacin was injected into the anterior chamber of the right eye of each animal. The rabbits were divided into five groups, and a sample of aqueous humor was collected 2, 4, 8, 24, and 48 h after administration of liposomes containing moxifloxacin administration. Moxifloxacin concentrations in the aqueous humor were analyzed using high-performance liquid chromatography. Results: The average size of the liposomes containing moxifloxacin was 60.5 ± 0.72 nm with a particle size distribution of 0.307. The encapsulation efficiency of moxifloxacin in liposomes was 92.24 ± 0.24%. The results of an in vivo release study of liposomes containing moxifloxacin, showed that the maximum moxifloxacin concentration was achieved within the first 2 h after administration (5.27 ± 1.09 mg/mL) and was followed by a decrease in intracameral concentration (0.35 ± 0.05 mg/mL) until the 24 h mark. Conclusions: The in vivo experiments resulted in liposomes containing moxifloxacin that were homogenous in size and exhibited high drug encapsulation efficiency. The results indicate that liposomes containing moxifloxacin offers a satisfactory aqueous humor release profile after intracameral application.
- Published
- 2017
26. Validação de método analítico espectrofotométrico UV para determinação de ácido úsnico em lipossomas Validation of a UV-spectrophotometric analytical method for the determination of usnic acid in liposomes
- Author
-
Marigilson Pontes de Siqueira-Moura, Mariane Cajubá Britto Lira, and Nereide Stela Santos-Magalhães
- Subjects
lcsh:Pharmacy and materia medica ,Lipossomas ,Liposomes ,lcsh:R ,Usnic acid ,lcsh:Medicine ,lcsh:RS1-441 ,Análise quantitativa ,Ultraviolet Spectrophotometry ,Espectrofotometria no ultravioleta ,Quantitative analysis ,Ácido úsnico - Abstract
O ácido úsnico (AU) é um composto de origem liquênica e tem demonstrado importantes atividades biológicas, tais como: antitumoral, antimicrobiano, antiviral, antiproliferativo e antiinflamatório. Os lipossomas são vesículas lipídicas contendo espaço aquoso interno e têm sido utilizados como carreadores coloidais de fármacos, principalmente na terapêutica de câncer e infecções bacterianas e fúngicas. O objetivo desse trabalho foi desenvolver e validar um método espectrofotométrico UV para determinação de ácido úsnico em lipossomas. Os parâmetros de validação linearidade, precisão, exatidão, robustez, limites de detecção e quantificação foram determinados segundo diretrizes internacionais de padronização e Farmacopéia Americana. A faixa de linearidade foi de 3 a 15 µg.mL-1, a equação de regressão: absorbância = 0,070 x [AU] (µg.mL-1) + 0,013 e r = 0,9997. A repetibilidade (coeficiente de variação) do método foi 1,96% e a precisão intermediária indicou que a diferença entre as médias foi estatisticamente insignificante (P < 0,05). A exatidão revelou média percentual de recuperação de 100,4%. O método foi robusto apesar da variação de temperatura e solventes. Os limites de detecção e quantificação do ácido úsnico foram de 0,34 e 1,13 µg.mL-1, respectivamente. O doseamento do ácido úsnico nos lipossomas foi de 96,8% (± 0,2). O método proposto é exato, preciso e reprodutível sendo capaz de quantificar o ácido úsnico em matéria-prima e em preparações farmacêuticas.The secondary lichen metabolite usnic acid [2,6-diacetyl-7,9-dihydroxy-8,9b-dimethyl-1,3(2H,9bH)-dibenzofuran] has demonstrated pharmacological potential activities such as antitumor, antimicrobial, antiviral, antiproliferative, and anti-inflammatory. Liposomes are vesicles composed of phospholipid bilayers surrounding aqueous compartments and they have been used as colloidal drug carriers. The aim of this study was to develop and validate a quantitative UV spectrophotometric method for determination of usnic acid in liposomal formulations. The validation parameters were assessed according to The International Conference on Harmonization (ICH) and American Pharmacopoeia guidelines. The linearity range was of 3-15 µg.mL-1, regression equation: absorbance = 0.070 x UA concentration (µg.mL-1) + 0.013, and r = 0.9997. The repeatability (relative standard deviation) of the method was 1.96% and intermediate precision indicated that the difference among mean was statistically insignificant (P < 0.05). The accuracy revealed a mean percentage recovery of 100.4% of usnic acid. The method was robust for the variation of temperature and solvent. The detection and quantization limits were found to be 0.34 and 1.13 µg.mL-1, respectively. The content of usnic acid in liposomes was of 96.8% (± 0.2). The proposed method is accurate, precise and reproducible for estimation of usnic acid as raw material and in pharmaceutical dosage forms such as liposomes.
- Published
- 2008
27. Nanotecnologia farmacêutica aplicada ao tratamento da malária Application of pharmaceutical nanotechnology to the treatment of malaria
- Author
-
Lúcio Figueira Pimentel, Agenor Tavares Jácome Júnior, Vanessa Carla Furtado Mosqueira, and Nereide Stela Santos-Magalhães
- Subjects
Vaccines ,Lipossomas ,lcsh:R ,Nanopartículas ,lcsh:Medicine ,lcsh:RS1-441 ,Malária ,Microparticles ,Malaria ,lcsh:Pharmacy and materia medica ,Vacinas ,Nanotecnolgia ,Liposomes ,Nanotechnology ,Nanoparticles ,Micropartículas - Abstract
Apesar do desenvolvimento tecnológico e científico, a malária permanece como um dos maiores problemas de saúde a serem combatidos. As estratégias modernas para o controle da doença prevêem ações conjuntas, como o combate do inseto vetor, diagnóstico rápido e preciso, garantia de terapêutica adequada, redução dos casos de resistência, além do desenvolvimento de novos agentes terapêuticos e vacina e através da otimização da ação de fármacos utilizados na atualidade. Os sistemas de liberação controlada de fármacos vêm recebendo atenção especial nesta área de pesquisa, com o desenvolvimento de estratégias para a veiculação de agentes bioativos e vacinas na forma de nanodispositivos tais como lipossomas, nanopartículas e micropartículas. Diversos nanossistemas já demonstraram eficácia na otimização de vacinas e quimioterápicos destinados ao controle da malária. Este artigo de revisão tem por objetivo avaliar o estado da arte na terapêutica da malária e demonstrar o potencial da nanotecnologia farmacêutica como ferramenta destinada ao combate da doença.In spite of living in a scientific and technological era, malaria continues to be one of the worldwide greatest health challenges. The state-of-the-art policy to keep malaria under control is expected to comprise joint-strategies, such as the vector control, fast diagnosis, therapeutic guarantee, resistance cutback, drug optimization and development of new therapeutic agents and vaccines. Nano and microcarrier systems have been receiving a special attention, including the development of strategies for carrying bioactive agents, vaccines through nanodevices, such as liposomes and nanoparticles, and microdevices, such as microparticles and microemulsions. Numerous nanosystems have already substantiated their effectiveness to optimize vaccines, insecticides, and chemotherapeutic agents applied to the control of malaria. This review is intended to explain the malaria scenario though the world, and to show the nanotechnology as a promising alternative for malaria control and treatment.
- Published
- 2007
28. Lipossomas e suas aplicações terapêuticas: estado da arte
- Author
-
Cícero Moraes Barros de Carvalho, Cinthia Meireles Batista, and Nereide Stela Santos Magalhães
- Subjects
Pharmacology ,chemistry.chemical_classification ,Liposome ,Lipossomas ,Aqueous solution ,Chemistry ,Biomolecule ,Sonication ,Vesicle ,Fosfolipídios ,Pharmaceutical Science ,Therapeutic applications ,Mononuclear phagocyte system ,Ligand (biochemistry) ,terapêuticas ,In vivo ,Liposomes ,Biophysics ,Stability ,Phospholipids - Abstract
Lipossomas são vesículas constituídas de uma ou mais bicamadas fosfolipídicas orientadas concentricamente em torno de um compartimento aquoso e servem como carreadores de fármacos, biomoléculas ou agentes de diagnóstico. A estabilidade dos lipossomas pode ser afetada por fatores químicos, físicos e biológicos. Após administração intravenosa, lipossomas convencionais são rapidamente capturados pelo sistema fagocitário mononuclear. Para evitar essa captura, lipossomas furtivos foram desenvolvidos, os quais apresentam a superfície modificada com componentes hidrofílicos. Para permitir a liberação seletiva do fármaco nos sítios alvos, ligantes de reconhecimento específico são conjugados na superfície de lipossomas. Em geral, os métodos de preparação de lipossomas incluem hidratação de um filme lipídico seguida de sonicação ou extrusão para redução do tamanho das vesículas. Os lipossomas são caracterizados quanto ao tamanho e composição química das vesículas e conteúdo do material encapsulado. Nesta revisão, constata-se que os lipossomas oferecem maior eficácia e segurança com relação aos tratamentos convencionais. Apesar de algumas formulações lipossomais serem comercializadas desde os anos 1980 para tratamento de infecções fúngicas sistêmicas e do câncer, problemas de ordem tecnológica e biológica fazem com que os lipossomas sejam ainda extensivamente estudados para desenvolvimento de formulações estáveis no organismo visando à terapia de várias doenças, principalmente do câncer. Liposomes are vesicles that consist of one or more concentric phospholipidic bilayers organized around an aqueous inner compartment. They are carriers of drugs, biomolecules and diagnostic agents. The stability of liposomes can be influenced by chemical or physical factors. Once injected in the circulatory system, conventional liposomes suffer uptake by the mononuclear phagocytic system. To avoid such a capture, non-conventional or Stealth® liposomes were developed, which are coated by hydrophilic components. Specific ligand had been incorporated in their surface so as to control the drug release and selectivity, thereby originating the targeted liposomes. In general, all preparation methods of liposomes include the hydration of lipidic film followed by sonication or extrusion to reduce the mean size of vesicles. After preparation, the vesicles are characterized by size, chemical constitution, and amount of encapsulated material. In this review it is shown that the liposomes offer effectiveness and safety in comparison with many conventional treatments. In spite of the existence of a few liposomal formulations available since early 80's, which are used for the treatment of systemic fungal infections and cancer, many technological and biological issues remain as a challenge. In this scenario, liposomes have extensively been studied in order to improve their in vivo stability in the treatment of several diseases, including cancer.
- Published
- 2007
29. Lipossomas e suas aplicações terapêuticas: estado da arte Liposomes and their therapeutic: state of art applications
- Author
-
Cinthia Meireles Batista, Cícero Moraes Barros de Carvalho, and Nereide Stela Santos Magalhães
- Subjects
lcsh:Pharmacy and materia medica ,terapêuticas ,Lipossomas ,Fosfolipídios ,Liposomes ,lcsh:R ,lcsh:Medicine ,lcsh:RS1-441 ,Therapeutic applications ,Stability ,Phospholipids - Abstract
Lipossomas são vesículas constituídas de uma ou mais bicamadas fosfolipídicas orientadas concentricamente em torno de um compartimento aquoso e servem como carreadores de fármacos, biomoléculas ou agentes de diagnóstico. A estabilidade dos lipossomas pode ser afetada por fatores químicos, físicos e biológicos. Após administração intravenosa, lipossomas convencionais são rapidamente capturados pelo sistema fagocitário mononuclear. Para evitar essa captura, lipossomas furtivos foram desenvolvidos, os quais apresentam a superfície modificada com componentes hidrofílicos. Para permitir a liberação seletiva do fármaco nos sítios alvos, ligantes de reconhecimento específico são conjugados na superfície de lipossomas. Em geral, os métodos de preparação de lipossomas incluem hidratação de um filme lipídico seguida de sonicação ou extrusão para redução do tamanho das vesículas. Os lipossomas são caracterizados quanto ao tamanho e composição química das vesículas e conteúdo do material encapsulado. Nesta revisão, constata-se que os lipossomas oferecem maior eficácia e segurança com relação aos tratamentos convencionais. Apesar de algumas formulações lipossomais serem comercializadas desde os anos 1980 para tratamento de infecções fúngicas sistêmicas e do câncer, problemas de ordem tecnológica e biológica fazem com que os lipossomas sejam ainda extensivamente estudados para desenvolvimento de formulações estáveis no organismo visando à terapia de várias doenças, principalmente do câncer.Liposomes are vesicles that consist of one or more concentric phospholipidic bilayers organized around an aqueous inner compartment. They are carriers of drugs, biomolecules and diagnostic agents. The stability of liposomes can be influenced by chemical or physical factors. Once injected in the circulatory system, conventional liposomes suffer uptake by the mononuclear phagocytic system. To avoid such a capture, non-conventional or Stealth® liposomes were developed, which are coated by hydrophilic components. Specific ligand had been incorporated in their surface so as to control the drug release and selectivity, thereby originating the targeted liposomes. In general, all preparation methods of liposomes include the hydration of lipidic film followed by sonication or extrusion to reduce the mean size of vesicles. After preparation, the vesicles are characterized by size, chemical constitution, and amount of encapsulated material. In this review it is shown that the liposomes offer effectiveness and safety in comparison with many conventional treatments. In spite of the existence of a few liposomal formulations available since early 80's, which are used for the treatment of systemic fungal infections and cancer, many technological and biological issues remain as a challenge. In this scenario, liposomes have extensively been studied in order to improve their in vivo stability in the treatment of several diseases, including cancer.
- Published
- 2007
30. Cytotoxicity of doxorubicin-loaded Con A-liposomes
- Author
-
Silene Carneiro do Nascimento, Rosa Maria Souto Maior, Nereide Stela Santos Magalhães, Hercília Maria Lins Rolim Santos, and Fernando Brederodes de Queiroz
- Subjects
Liposome ,biology ,Cell growth ,organic chemicals ,technology, industry, and agriculture ,macromolecular substances ,Molecular biology ,carbohydrates (lipids) ,Concanavalin A ,Cell culture ,Drug Discovery ,polycyclic compounds ,biology.protein ,medicine ,Cytotoxic T cell ,Doxorubicin ,Cytotoxicity ,Drug carrier ,medicine.drug - Abstract
The present study investigated the potential of Concanavalin A lectin (Con A) conjugated to liposomes (Con A-liposomes) for targeting doxorubicin (DOX) to cells. The physicochemical properties and the cytotoxicity of DOX-loaded Con A-liposomes were evaluated. DOX-loaded Con A-liposomes were prepared by incubation of DOX-loaded liposomes with a Con A-SATA derivative. Lectin biological activity was monitored before and after conjugation by a hemagglutinating assay. The cytotoxicity of DOX-loaded Con A-liposomes was evaluated in terms of the inhibition of NCI-H299 and HEp-2 cell proliferation using the MTT method. The affinity of lectinized liposomes with these cells was thus assessed by evaluating the cytotoxic effect of the DOX released into cells. Stable DOX-loaded Con A-liposomes were obtained and their high affinity for cells was corroborated. The encapsulation of DOX into Con A-liposomes produced an inhibition of roughly 70% of Hep-2 cell proliferation and 50% of cell inhibition was verified on HCI-H292. DOX in solution was able to inhibit only 20% of cell proliferation for both cell lines. Unloaded Con A-liposomes were not cytotoxic. The encapsulation of DOX into Con A-liposomes improves drug penetration into cells, thereby enhancing its cytotoxicity, especially in Hep-2 cells. Drug Dev. Res. 67:430–437, 2006. © 2006 Wiley-Liss, Inc.
- Published
- 2006
31. Pharmacokinetic evaluation of lamivudine and zidovudine tablets in human plasma
- Author
-
João Eudes do Nascimento, Nereide Stela Santos Magalhães, Roseane Maria Ribeiro, Antonio J. Alves, and Adriana Pontes
- Subjects
Lamivudina ,Pharmacology ,Physics ,Farmacocinética ,Lamivudine ,Pharmacokinetic ,Pharmaceutical Science ,Zidovudina ,Zidovudine ,Humanities - Abstract
Este estudo se propõe a avaliar o perfil farmacocinético de comprimidos contendo lamivudina e zidovudina associados, produzidos pelo Laboratório Farmacêutico do Estado de Pernambuco - LAFEPE. O medicamento foi administrado em 10 voluntários sadios e foram observadas as concentrações plasmáticas dos dois anti-retrovirais durante 12 horas. A partir das concentrações plasmáticas foi possível encontrar os parâmetros farmacocinéticos de ambos os fármacos através de cálculos estatísticos. Os resultados obtidos foram comparados com aqueles resultantes de experimentos realizados por outros autores descritos neste trabalho, em que se verificou não haver diferenças significativas entre os valores encontrados e os descritos na literatura e que o fato dos anti-retrovirais estarem associados na mesma formulação não modificou o perfil cinético de nenhuma das substâncias. The purpose of this work was an evaluation of the pharmacokinetic profile from lamivudine and zidovudine combination tablets, produced by Laboratório Farmacêutico do Estado de Pernambuco - LAFEPE. The formulation was administered in 10 volunteers and the concentration-time serum profile was observed from both antiretroviral agents during 12 hours. From concentration-time serum profile the pharmacokinetic parameters for both drugs were calculated by statistical methods. The results were compared with those from experiments carried out by other authors referred in this paper. Differences between the results obtained herein and those from other authors were not significant. The kinetic profile for both substances was not modified by the anti-retroviral combination.
- Published
- 2004
32. Avaliação farmacocinética de comprimidos contendo lamivudina e zidovudina em plasma humano Pharmacokinetic evaluation of lamivudine and zidovudine tablets in human plasma
- Author
-
João Eudes do Nascimento, Nereide Stela Santos Magalhães, Roseane Maria Ribeiro, Adriana Pontes, and Antônio José Alves
- Subjects
Lamivudina ,lcsh:Pharmacy and materia medica ,Farmacocinética ,Lamivudine ,lcsh:R ,Pharmacokinetic ,lcsh:Medicine ,lcsh:RS1-441 ,Zidovudina ,Zidovudine - Abstract
Este estudo se propõe a avaliar o perfil farmacocinético de comprimidos contendo lamivudina e zidovudina associados, produzidos pelo Laboratório Farmacêutico do Estado de Pernambuco - LAFEPE. O medicamento foi administrado em 10 voluntários sadios e foram observadas as concentrações plasmáticas dos dois anti-retrovirais durante 12 horas. A partir das concentrações plasmáticas foi possível encontrar os parâmetros farmacocinéticos de ambos os fármacos através de cálculos estatísticos. Os resultados obtidos foram comparados com aqueles resultantes de experimentos realizados por outros autores descritos neste trabalho, em que se verificou não haver diferenças significativas entre os valores encontrados e os descritos na literatura e que o fato dos anti-retrovirais estarem associados na mesma formulação não modificou o perfil cinético de nenhuma das substâncias.The purpose of this work was an evaluation of the pharmacokinetic profile from lamivudine and zidovudine combination tablets, produced by Laboratório Farmacêutico do Estado de Pernambuco - LAFEPE. The formulation was administered in 10 volunteers and the concentration-time serum profile was observed from both antiretroviral agents during 12 hours. From concentration-time serum profile the pharmacokinetic parameters for both drugs were calculated by statistical methods. The results were compared with those from experiments carried out by other authors referred in this paper. Differences between the results obtained herein and those from other authors were not significant. The kinetic profile for both substances was not modified by the anti-retroviral combination.
- Published
- 2004
33. Antifungal activity of a liposomal itraconazole formulation in experimental Aspergillus flavus keratitis with endophthalmitis
- Author
-
Isabella Macário Ferro Cavalcanti, Almir Gonçalves Wanderley, Rejane Pereira Neves, Nereide Stela Santos Magalhães, André Ferraz Goiana Leal, Caroline Sanuzi Quirino Medeiros, and Melyna Chaves Leite
- Subjects
Antifungal Agents ,Itraconazole ,Veterinary (miscellaneous) ,medicine.medical_treatment ,Chemistry, Pharmaceutical ,Intraperitoneal injection ,Aspergillus flavus ,Pharmacology ,Aspergillosis ,Applied Microbiology and Biotechnology ,Microbiology ,Keratitis ,Endophthalmitis ,medicine ,Animals ,Humans ,Fungal keratitis ,Rats, Wistar ,Colony-forming unit ,biology ,business.industry ,medicine.disease ,biology.organism_classification ,Rats ,Liposomes ,Female ,business ,Agronomy and Crop Science ,medicine.drug - Abstract
The aim of this study was to assess the efficacy of topical application of a liposomal formulation of itraconazole for the treatment of experimental keratitis with endophthalmitis caused by Aspergillus flavus. The liposomes were obtained by the lipid film hydration method followed by sonication. Adult female Wistar rats (weighing 200-220 g) were immunosuppressed by intraperitoneal injection of 150 mg/kg of cyclophosphamide 3 days before infection by exposure to the fungus A. flavus (10(7) spores/ml). Forty-eight hours later, the animals were treated with the liposomal formulation. For comparison, one group of animals (n = 6) was treated with the same drug not encapsulated. At the end of the experiment, the animals were evaluated for clinical signs and number of colony forming units (CFU/g), along with direct microscopic examination. The results indicated that the liposomal formulation of itraconazole has better antifungal activity than the unencapsulated drug in the treatment of fungal keratitis with endophthalmitis caused experimentally by A. flavus in Wistar rats.
- Published
- 2014
34. Automated search for potentially active compounds by using cluster trees
- Author
-
Sócrates Cabral de Holanda Cavalcanti, Irwin Rose Alencar De Menezes, H. M. de Oliveira, Nereide Stela Santos Magalhães, Antonio J. Alves, and Adriano Antunes De Sousa Araújo
- Subjects
Pharmacology ,Quantitative structure–activity relationship ,Chemistry ,Stereochemistry ,Organic Chemistry ,Dendrogram ,General Medicine ,computer.software_genre ,Hierarchical clustering ,ComputingMethodologies_PATTERNRECOGNITION ,U-plasminogen activator ,Drug Discovery ,Benzene derivatives ,Cluster (physics) ,Data mining ,Cluster tree ,computer - Abstract
A new agglomerative (bottom-up) hierarchical cluster technique referred to as the Adaptive Mean-Linkage algorithm is derived. Cluster algorithms are also offered as a tool to explore the descriptor space knowing the quantitative structure–activity relationship (QSAR). The substituents are clustered building a dendrogram (cluster tree) per site. Choosing appropriate pathways on such cluster trees according to the QSAR equation, an automated search for potentially active substituted compounds can be performed. Applications to a series of substituted phenylguanidines with anticancer activity are focused illustrating this approach.
- Published
- 1999
35. Ab initio and semiempirical (AM1) structural studies of O-(2,2,2-trichloro-1-hydroxyethyl)-benzamidoxime and its hydrogen bonded dimer
- Author
-
Rajendra M. Srivastava, Manuel Braga, Nereide Stela Santos Magalhães, and Ricardo L. Longo
- Subjects
Hydrogen ,Chemistry ,Hydrogen bond ,Dimer ,Organic Chemistry ,Ab initio ,chemistry.chemical_element ,Dihedral angle ,Condensed Matter Physics ,Biochemistry ,Analytical Chemistry ,Inorganic Chemistry ,Bond length ,Crystallography ,chemistry.chemical_compound ,Molecular geometry ,Molecular orbital ,Physical and Theoretical Chemistry ,Spectroscopy - Abstract
Ab initio and semiempirical (AM1) molecular orbital calculations have been performed on O-(2,2,2-trichloro-1-hydroxyethyl)-benzamidoxime. The calculated values of the bond angles, bond lengths and dihedral angles have been compared witht hose obtained by X-ray crystallography. There is good agreement between the experimental geometry and the calculated structure at the ab initio and semiempirical levels. The hydrogen bonded dimers of two S enantiomers (SS dimer) and of RS enantiomer monomers have been studied with the AM1 method. The RS dimer calculated structure agrees quite well with the experimental X-ray data, having two hydrogen bonds between the OH group and the nitrogen atom of the C NO group. However, the calculated hydrogen bond patterns in the SS dimer are different, with one H-bond between the OH and C NO groups (OH⋯N) and another one between the NH2 and OH groups (HNH ⋯ OH).
- Published
- 1996
36. Cytotoxicity of doxorubicin‐loaded Con A‐liposomes.
- Author
-
Hercília Maria Lins Rolim Santos, Fernando Brederodes de Queiroz, Rosa Maria Souto Maior, Silene Carneiro do Nascimento, and Nereide Stela Santos Magalhães
- Published
- 2006
37. Uma revisão das atividades biológicas da trans-desidrocrotonina, um produto natural obtido de Croton cajucara
- Author
-
Nereide Stela Santos Magalhães, Marcília Pinheiro da Costa, F. E. S. Gomes, and Maria Aparecida Medeiros Maciel
- Subjects
fitoquímica ,lcsh:RS1-441 ,Secondary metabolite ,nanobiotechnology ,atividade biológica ,lcsh:Pharmacy and materia medica ,chemistry.chemical_compound ,medicine ,General Pharmacology, Toxicology and Pharmaceutics ,Croton cajucara ,Stem bark ,biology ,Traditional medicine ,Euphorbiaceae ,trans-desidrocrotonina ,trans-dehydrocrotonin ,biology.organism_classification ,Bioactive compound ,biologic activities ,chemistry ,DCTN ,phytochemistry ,Diterpene ,medicine.drug ,nanobiotecnologia - Abstract
Croton cajucara Beth (Euphorbiaceae) uma espécie medicinal nativa da região Amazônica do Brasil, onde é vulgarmente conhecida como 'sacaca', representa um recurso terapêutico eficaz no tratamento e cura de várias doenças. O metabólito majoritário trans-desidrocrotonina (DCTN), isolado das cascas do caule desta planta, encontra-se correlacionado com grande parte das propriedades medicinais da sacaca. Este artigo de revisão, descreve os resultados fitoquímicos e farmacológicos que foram realizados com o diterpeno do tipo clerodano DCTN, bem como seus derivados semi-sintéticos. Adicionalmente, apresenta perspectivas para a biodisponibilização deste protótipo de fármaco em nanosistemas. Croton cajucara Beth (Euphorbiaceae) is a plant found in the Amazonian Region of North Brazil, where it is popularly known as sacaca. The major secondary metabolite, trans-dehydrocrotonin (DCTN) a clerodane-type diterpene, isolated from the stem bark is a chief bioactive compound of Croton cajucara. This review describes results of extensive pharmacological studies of DCTN, as well as its semi-synthetic derivatives, and also presents insights into the use of DCTN as a therapeutic agent and some potential advantages of its incorporation in drug delivery systems.
38. Ceftazidime/Tobramycin Co-Loaded Chitosan-Coated Zein Nanoparticles against Antibiotic-Resistant and Biofilm-Producing Pseudomonas aeruginosa and Klebsiella pneumoniae
- Author
-
Luís André de Almeida Campos, Azael Francisco Silva Neto, Alexsandra Maria Lima Scavuzzi, Ana Catarina De Souza Lopes, Nereide Stela Santos-Magalhães, and Isabella Macário Ferro Cavalcanti
- Subjects
antibiotics ,infections ,nanocarriers ,bacterial resistance ,combination therapy ,Medicine ,Pharmacy and materia medica ,RS1-441 - Abstract
This study aimed to co-encapsulate ceftazidime and tobramycin in zein nanoparticles coated with chitosan and to characterize and evaluate the antibacterial and antibiofilm activity against antibiotic-resistant Pseudomonas aeruginosa and Klebsiella pneumoniae. Zein nanoparticles, synthesized using the nanoprecipitation method, were characterized by their particle size (Ø), polydispersity index (PDI), zeta potential (ζ), pH, and encapsulation efficiency (%EE). The chitosan coating provided stability, and physicochemical analyses revealed chemical interactions, efficient drug encapsulation, and thermal stability. The release kinetics demonstrated controlled release in simulated gastric and intestinal pH. The antibacterial activity, assessed by minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC), indicated effectiveness against both pathogens. Antibiofilm assays, conducted using the crystal violet method, demonstrated the inhibition and eradication of biofilms. The chitosan-coated zein nanoparticles with CAZ and/or TOB exhibited Ø (315–335 nm), PDI (55%). Notably, the co-encapsulation formulation (CAZ–TOB–ZNP–CH) showed enhanced antibacterial and antibiofilm activities compared to the individual formulations. These findings suggest that the developed nanoparticles present a promising alternative for treating respiratory and intestinal infections caused by antibiotic-resistant and biofilm-producing P. aeruginosa and K. pneumoniae.
- Published
- 2024
- Full Text
- View/download PDF
39. Nanodispersões de cristais líquidos como sistemas de liberação de fotossensibilizadores na terapia fotodinâmica do câncer de pele: avaliação in vitro e in vivo da permeação e retenção cutâneas
- Author
-
Fábia Cristina Rossetti, Maria Vitoria Lopes Badra Bentley, Iouri Borissevitch, Armando da Silva Cunha Junior, Nereide Stela Santos Magalhães, and Antonio Claudio Tedesco
- Abstract
A Terapia Fotodinâmica (TFD) é uma modalidade de tratamento de câncer relativamente nova e promissora. Baseia-se na utilização de uma substância fotossensibilizante e luz para provocar um dano seletivo ao tecido alvo, sendo que a seletividade ao órgão/tecido deve ser reconhecida como uma das vantagens no tratamento do câncer. Atualmente, o desenvolvimento de sistemas de liberação e promotores de absorção visando a otimização da liberação tópica de fotossensibilizadores, apresenta-se como um promissor e inexplorado campo de pesquisa na TFD do câncer de pele. Sistemas de liberação compostos por monoleína, um lipídeo polar biocompatível, e água são capazes de aumentar a permeação de fármacos na pele, além de serem capazes de controlar a liberação dos mesmos. No presente estudo foram desenvolvidas e caracterizadas nanodispersões de cristais líquidos como sistemas de liberação para os fotossensibilizadores Protoporfirina IX (PpIX) e Ftalocianinas de Zinco (ZnPc) e Cloro Alumínio (ClAlPc), objetivando otimizar a penetração cutânea destes na epiderme. As nanodispersões foram avaliadas em relação a sua eficiência de encapsulação, estabilidade física e química dos fotosensibilizadores veiculados, bem como a permeação e retenção cutânea in vitro e in vivo por microscopia de fluorescência. Estudos de pré-tratamento foram realizados, objetivando-se verificar o efeito promotor de absorção cutânea das nanodispersões desenvolvidas. Os experimentos de eficiência de encapsulação e estabilidade mostraram que as nanodispersões são um sistema de liberação adequado a aplicação tópica de fotosensibilizadores. Os experimentos in vitro mostraram que as nanodispersões aumentaram a penetração cutânea da PpIX e ClAlPc no estrato córneo em, respectivamente, 3,4 e 11,7 vezes, quando comparadas a formulação controle. Na epiderme mais derme sem estrato córneo, os aumentos promovidos pelas nanodispersões foram de 6,5 e 9,7 vezes para a PpIX e ClAlPc. No experimento in vivo as nanodispersões aumentaram a penetração cutânea da PpIX e ClAlPc no estrato córneo em, respectivamente, 13,7 e 7,0 vezes, quando comparadas ao controle, sendo que na epiderme mais derme sem estrato córneo somente as nanodispersões foram capazes de promover a penetração cutânea destes fotossensibilizadores nestas camadas da pele. A visualização da penetração cutânea dos fotosensibilizadores por microscopia de florescência confirmou os resultados obtidos nos experimentos in vivo de que as nanodispersões foram superiores ao controle em aumentar a penetração cutânea da PpIX e ClAlPc em camadas mais profundas da pele. Os resultados obtidos mostraram que as nanodispersões desenvolvidas são sistemas de liberação promissores para a PpIX e ClAlPc no tratamento do câncer de pele na TFD uma vez que aumentaram in vitro e in vivo a penetração cutânea destes na epiderme. Photodynamic therapy (PDT) is a relatively new and promising cancer treatment modality that involves the administration of a photosensitizing drug and its subsequent activation by light to produce activated oxygen species that selectively destroy target cells. Recently, PDT to treat skin cancer is focused on the development of drug delivery systems and penetration enhancers that aim to optimize the topical release of photosensitizers. Drug delivery systems based on monoolein, a biocompatible polar lipid, and water are able to enhance the cutaneous penetration of drugs and control their release. Liquid crystal nanodispersions were developed and characterized in this project as delivery systems for the photosensitizers Protoporphyrin IX (PpIX) and Zinc and Chloroaluminum phthalocyanines (ZnPc and ClAlPc), aiming to increase their topical penetration in the epidermis. The physical stability of the nanodispersions, their encapsulation efficiency and the chemical stability of the photosensitizers incorporated were tested. In vitro and in vivo skin penetration tests were performed to verify the efficacy of the nanodispersions in enhancing the topical delivery of the photosensitizers. In vitro pre-treatment tests were conducted to determine if the nanodispersions are able to increase the skin penetration of the photosensitizers by a penetration enhancing effect. Stability and encapsulation efficiency tests showed that nanodispersions are an adequate topical delivery system for photosensitizers. In vitro experiments showed increased PpIX and ClAlPc penetration in the stratum corneum, respectively, of 6.5- and 9.7-fold for the nanodispersions compared to the control. In the epidermis with dermis, without stratum corneum, the increase promoted by the nanodispersions for PpIX and ClAlPc were, respectively, of 6.5- and 9.7-fold. Experimental retention in vivo confirmed that when the nanodispersions were used as carrier, PpIX and ClAlPc concentrations in the stratum corneum were about 13.7- and 7.0-fold higher, respectively, than control. In the epidermis with dermis, without stratum corneum, only the nanodispersions were able to promote the skin penetration of these photosensitizers. Visualization of PpIX and ClAlPc skin penetration by fluorescence microscopy confirmed that the nanodispersions increased the skin penetration of these photosensitizers in deeper skin layers. The results showed that the nanodispersions are promising topical delivery systems in the PDT of skin cancer once they increased in vitro and in vivo the topical penetration of PpIX and ClAlPc in the epidermis.
- Published
- 2015
40. Development and characterization of topical delivery systems based on liquid crystals for siRNA in gene therapy
- Author
-
Lívia Vieira Depieri, Maria Vitoria Lopes Badra Bentley, and Nereide Stela Santos Magalhães
- Abstract
A terapia gênica por interferência de RNA (RNAi) trata-se de um processo de silenciamento pós-transcricional capaz de suprimir a expressão de um determinado gene. A RNAi é uma proposta terapêutica promissora para o tratamento de muitas doenças severas que ainda não possuem cura ou terapias bem definidas. Porém, é necessário o desenvolvimento de sistemas de liberação clinicamente adequados, seguros e eficazes para se viabilizar essa nova terapêutica, uma vez que obstáculos na administração e distribuição in vivo comprometem o uso clínico dos siRNAs (small interfering RNA). Paralelamente, a liberação tópica de siRNAs surge como uma alternativa promissora para o tratamento de patologias cutâneas. Neste contexto, a presente pesquisa teve como objetivo o desenvolvimento de um sistema de liberação baseado em nanotecnologia para a liberação tópica de siRNAs, visando introduzir a terapia gênica como nova abordagem para o tratamento de patologias cutâneas. Como sistema de liberação, foram desenvolvidas nanodispersões líquido-cristalinas aquosas, compostas por monoleína (MO), um lipídeo polar biocompatível, associadas ou não com ácido oléico (AO). Foram incorporados a esses sistemas os adjuvantes catiônicos polietilenoimina (PEI) e oleilamina (OAM) para obtenção das nanodispersões. Dentre as nanodispersões aquosas desenvolvidas, foram escolhidas as preparações com as menores concentrações de adjuvantes catiônicos, a saber: MO e OAM a 0,4%, MO e PEI a 0,4%, MO, AO e OAM a 2,5% e MO, AO e PEI a 1,0%. Estas formulações apresentaram: reduzido tamanho médio das partículas, baixa polidispersividade, valores de potencial zeta positivos (característica interessante para interação com as moléculas de siRNA que apresentam carga negativa), baixa citotoxicidade in vitro e foram capazes de complexar o siRNA na concentração final de 2,5 ?M. A análise de difração de raios X caracterizou a fase líquido-cristalina desses sistemas como hexagonal, exceto a nanodispersão MO e PEI a 0,4% que foi caracterizada como uma mistura de fase hexagonal e cúbica. As nanodispersões obtidas foram capazes de aumentar a penetração cutânea de siRNA in vitro. Face aos resultados obtidos, podemos concluir que as formulações desenvolvidas são sistemas de liberação de base nanotecnológica promissores para administração tópica de siRNA para o tratamento de patologias cutâneas na terapia gênica. Gene therapy by RNA interference (RNAi) is a post-transcriptional silencing process that can suppress the expression of a particular gene. The RNAi is a promising therapeutic approach for the treatment of many severe diseases that have no cure or well-defined treatments. However, the development of clinically appropriate, safe and effective delivery systems is necessary to enable this new therapy, since obstacles in the in vivo administration and distribution committed the clinical use of siRNAs (small interfering RNA). In addition, the topical delivery of siRNAs appears as a promising alternative for the treatment of cutaneous pathologies. In this context, this research aimed to develop a delivery system based on Nanotechnology for the topical delivery of siRNAs, aiming to introduce gene therapy as a new approach for the treatment of skin disorders. As a delivery system, liquid-crystalline nanodispersions, composed by monoolein (MO), a polar biocompatible lipid, associated or not with oleic acid (OA) were developed. The cationic adjuvants polyethylenimine (PEI) and oleylamine (OAM) were incorporated into these systems to obtain the nanodispersions. Among the aqueous nanodispersions developed, preparations with lower concentration of cationic adjuvant were chosen, these consisting of: MO and OAM at 0.4%, MO and PEI at 0.4%, MO, OA and OAM at 2.5% and MO, OA and PEI at 1.0%. These formulations presented: reduced average particle size, low polydispersity, positive values of zeta potential (an interesting feature for interacting with the siRNA molecules that have a negative charge), low cytotoxicity in vitro and they were able to complex the siRNA at a final concentration of 2.5 ?M. The X-ray diffraction analysis characterized the liquid crystalline phase of these systems as hexagonal, except the nanodispersion MO and PEI at 0.4% which was characterized as a mixture of cubic and hexagonal phases. The nanodispersions obtained were able to increase the skin penetration of siRNA in vitro. With the results obtained, we can conclude that the formulations developed are delivery systems based on nanotechnology, promising for topical administration of siRNA for the treatment of cutaneous diseases in gene therapy.
- Published
- 2012
41. Dendrimers as drug carriers for protoporphyrin IX to topical photodynamic therapy of skin cancer
- Author
-
Luciana Mattoso Pires de Campos Araujo, Renata Fonseca Vianna Lopez, Sílvia Stanisçuaski Guterres, Nereide Stela Santos Magalhães, and Valtencir Zucolotto
- Subjects
education.field_of_study ,Protoporphyrin IX ,Iontophoresis ,medicine.medical_treatment ,Population ,Photodynamic therapy ,Penetration (firestop) ,Porphyrin ,chemistry.chemical_compound ,chemistry ,Dendrimer ,medicine ,education ,Drug carrier ,Nuclear chemistry - Abstract
A protoporfirina IX (PpIX) é uma substância fotodinâmicamente ativa, entretanto, devido a sua alta lipofilia apresenta dificuldades para penetrar nas camadas mais profundas da pele, não sendo administrada topicamente. Assim, o objetivo deste trabalho é estudar a influência de diferentes tipos de dendrímeros de poliamidoamina (PAMAM) na solubilidade, penetração cutânea e penetração celular da PpIX com o intuito de melhorar a terapia fotodinâmica tópica (TFD) com esta substância. Os estudos de solubilidade da PpIX na presença dos dendrímeros PAMAM G4, G4.5 e G4-OH mostraram que o dendrímero PAMAM G4.5, foi o que solubilizou a maior quantidade de PpIX seguido do PAMAM-OH G4> PAMAM G4 > tampão HEPES. A partir dos estudos de solubilidade foi possível identificar que a PpIX na presença dos dendrímeros PAMAM G-4.5 e G4-OH apresentam diagramas de solubilidade tipo BS, e BI quando na presença do PAMAM G4. Os estudos de varredura em espectroscopia UV-VIS e fluorescência indicaram a presença de agregados principalmente nos complexos PpIX-PAMAM G-4.5 obtidos. Os complexos solúveis PpIX-PAMAM G4-OH apresentaram tamanho médio de 13,2 nm, e potencial zeta de -3,41. Já os complexos com o dendrímero PAMAM G-4.5 apresentaram uma população bidispersa, com tamanhos de 31 e 391 nm e um potencial zeta de -17,3. A análise de DSC e espectroscopia de infravermelho com transformada de Fourrier mostraram alterações nas características da PpIX em solução e quando complexada com os dendrímeros. Nos estudos de permeação e retenção cutânea passiva com os complexos contendo 0,006 mg/mL de PpIX, estes não aumentaram a penetração cutânea do fármaco. No entanto, a complexação permitiu que maiores quantidades de PpIX ficassem disponíveis na solução doadora, e um aumento significativo na penetração da PpIX foi observado quando experimentos com 1 mg/mL de PpIX complexada foram conduzidos; ademais notou-se uma possível ação promotora do dendrímero PAMAM G4-OH. Nos estudos de iontoforese verificou-se que a corrente elétrica não aumentou a penetração da PpIX em relação aos experimentos passivos quando o complexo PpIX-PAMAM G4.5 foi estudado, provavelmente devido a maior liberação da PpIX do complexo na presença da corrente elétrica, aumentando os agregados que são grandes o suficientes para não penetrar na pele. Por outro lado, a iontoforese anódica aumentou a penetração do complexo PpIX-PAMAM G4-OH por eletrosmose até as camadas mais profundas da pele, levando a PpIX inclusive até a solução receptora. Os estudos de cultura de células tumorais confirmaram a capacidade dos dendrímeros em aumentar a penetração da PpIX através de membrana. A complexação melhorou a distribuição da PpIX no interior das células e aumentou significativamente a fotocitotoxicidade desta porfirina. Protoporphyrin IX (PpIX) is a photodynamic active drug that is not topically administered due to its high lipophilicity and consequent low penetration in deep skin layers. The aim of this work is to study the influence of different types of polyamidoamine dendrimers (PAMAM) in PpIX solubility, skin and cell penetration to enhance topical photodynamic therapy (PDT). The solubility studies of PpIX in the presence of PAMAM dendrimers G4, G4.5 and G4-OH demonstrated that the G4.5 solubilized the greatest amount of PpIX, followed by PAMAM G4-OH> PAMAM G4> HEPES buffer. Solubility studies showed that the PpIX in the presence of PAMAM dendrimers G-4.5 and G4-OH presented solubility diagrams of BS type, and BI type in the presence of PAMAM G4. Studies of scanning UV-VIS and fluorescence indicated the presence of aggregates mainly in PpIX-PAMAM G-4.5 solution. The PpIX-PAMAM G4-OH complexes showed a mean size of 13.2 nm and zeta potential of -3.41; the complexes with PAMAM dendrimer G-4.5 had a bi-dispersed population, with sizes of 31 and 391 nm and a zeta potential of -17.3. The analysis of DSC and Fourier transform infrared Fourier showed changes in the characteristics of PpIX when it was complexed with the dendrimers. Passive skin permeation and retention studies with the complexes containing 0.006 mg/ml PpIX had not increased PpIX penetration, however, the complexation allowed greater amounts of PpIX to become available in the donor solution, and experiments with 1 mg/mL of PpIX increased significantly the penetration of the drug. Moreover, dendrimer PAMAM G4-OH seemed to act as a penetration enhancer. Iontophoresis did not increase skin penetration of PpIX compared to passive studies when the PpIX-PAMAM G4.5 was studied, likely because the electric current increased PpIX release from the complexes, forming aggregates large enough to not penetrate through the skin. On the other hand, anodic iontophoresis increased significantly the penetration of the PpIX-PAMAM G4-OH by eletrosmosis, spreading the drug to deep skins layers, also reaching the receiver solution. Studies in cell culture confirmed the ability of dendrimers to increase the penetration of PpIX through the membrane. The complexation improved the distribution of PpIX within the cells and significantly increased photocytotoxic of the porphyrin.
- Published
- 2011
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.